Canaan stock maintained at Buy by StoneX on Texas power approval

StoneX maintained a Buy rating and $1.00 price target on Canaan Inc. (NASDAQ:CAN) after its Q3 2026 results showed a 96% product revenue decline. The company reported a gross loss, with a profit due to bitcoin's rally. Canaan's gross profit margin is -4.77% over the past year, and its stock has fallen 83%. The company received a conditional approval from ERCOT for its 1 GW Texas site. Analyst Mark Palmer called the ERCOT disclosure 'the most consequential in the company’s recent history.'

Original reporting
Published Nov 13, 2026, 12:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
$CAN
Bullish
medium confidence
Mentioned
$CAN · $SNEX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CANBullishMed
01

Why it matters

The regulatory approval reduces operational uncertainty, potentially supporting a price rebound, but the company's fundamentals remain weak.

02

Market read

A micro‑cap crypto‑mining firm receives a key power‑grid approval, which may influence its valuation and sector peers.

03

What to watch

Canaan's heavy reliance on Bitcoin price volatility and its negative gross margin remain significant risks.

Relevance 7/10Novelty 7/10Timing: today

Background

Canaan Inc. is a Bitcoin mining equipment manufacturer whose stock has fallen sharply amid weak crypto markets. The recent ERCOT classification could be a catalyst for recovery.

Company-level read

Ticker impact

$CANBullishMedium confidence
Context

StoneX maintains a Buy rating on Canaan Inc. after the company receives a conditional ERCOT Load Firm classification for its Texas power project.

Expected impact

likely upward pressure as investors price in the power connection approval

Evidence & confidence

The conditional classification enables Canaan to proceed with its large‑scale mining facility, addressing a major risk factor and may boost future earnings.

Market effects

May improve sentiment for other crypto‑mining firms reliant on large power contracts.

Texas power market sees a new large‑scale consumer, modestly increasing demand outlook.

Limited to the niche crypto‑mining sector; no broad macro impact.

Counterpoint

The approval is conditional and may still face delays; the stock's massive decline suggests deeper structural issues.

Key entities

  • StoneX

    Maintains Buy rating on Canaan.

  • ERCOT

    Provided conditional Load Firm classification for Canaan's Texas site.

Related articles

$CANMed

Canaan Inc. (CAN): Financial results for Q3 2026

Canaan Inc. (CAN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Canaan Inc. Reports Unaudited Third Quarter 2026 Financial Results Received conditional “Studied Load – Firm” classification under ERCOT’s Batch Zero process for 1 GW Duval County power project Advanced second 1 GW Texas power project, expanding development pipeline

$BLSHHighAI 8/10

Bullish stock initiated at Buy by StoneX on tokenization potential

StoneX initiated coverage on Bullish (NYSE:BLSH) with a Buy rating and $42 price target, citing tokenization potential. The company's shares have fallen 48% since September, trading at $21.31. Bullish plans to acquire Equiniti, positioning it as a transfer agent for public companies. Analysts have mixed views on the acquisition, with some upgrading and others lowering targets.

$RXOMedAI 8/10

RXO stock holds at StoneX as freight rates improve ahead of CHRW deal

StoneX reiterated a Hold rating on RXO, Inc. (NYSE:RXO) after its Q3 adjusted EBITDA of $51M exceeded estimates. RXO's truckload gross profit and margins improved, with spot rates and contract pricing supporting brokerage margins. RXO's stock has surged 120% YTD. C.H. Robinson's $5.8B acquisition of RXO is pending, with mixed analyst reactions on ratings and price targets.